
    
      Healthy subjects will be enrolled and will receive single doses of 2 test inhalation products
      and one reference inhalation product according to a three-period cross-over design. Subjects
      will use the patient instruction leaflet to understand how each inhaler is administered.
      Plasma tiotropium levels will be measured pre-dose and over 8 hours post-dose.
    
  